Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

NCT00190853 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Stress Incontinence

Interventions

DRUG: Duloxetine

Sponsor

Eli Lilly and Company